References
- Brisacier A-C. Tableau de bord «Traitements de substitution aux opiacés». https://www.ofdt.fr/BDD/publications/docs/TabTSO180206.pdf. Published February 2018. Accessed December 21, 2018.
- Bach P, Hartung D. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addict Sci Clin Pract. 2019;14(1):30.
- Ministère de la solidarité et de la santé. La réduction des risques et des dommages chez les usagers de drogues. https://solidarites-sante.gouv.fr/prevention-en-sante/addictions/article/la-reduction-des-risques-et-des-dommages-chez-les-usagers-de-drogues. Published January 14, 2020. Accessed July 22, 2020.
- Claroux-Bellocq D, De Bailliencourt S, Saint-Jean F, et al. Substitute drug treatment for opiate addiction in Metropolitan France in 2000: data from the General Healthcare Fund. Rev Médicale L’Assurance Mal. 2003;34(2):93–102.
- INSERM. Dispositifs de réduction des risques en France. http://www.ipubli.inserm.fr/bitstream/handle/10608/87/Chapitre_15.html. Published 2010. Accessed March 31, 2020.
- Mission permanente de lutte contre la toxicomanie, devenue la mission interministérielle de lutte contre les drogues et les conduites addictives (MILDECA). Salles de consommation à moindre risque. https://www.drogues.gouv.fr/comprendre/ce-qu-il-faut-savoir-sur/salle-de-consommation-moindre-risque. Published November 13, 2018. Accessed April 16, 2020.
- Ordre National des Pharmaciens. Le code de déontologie des pharmaciens. http://www.ordre.pharmacien.fr/Nos-missions/Assurer-le-respect-des-devoirs-professionnels/Code-de-deontologie. Published September 7, 2016. Accessed November 20, 2018.
- ASUD. Non-délivrance des TSO : L’Observatoire des droits des usagers tire la sonnette d’alarme. http://www.asud.org/2018/11/03/traitements-de-substitution-aux-opiaces-lodu-tire-la-sonnette-dalarme/. Published November 3, 2018. Accessed December 21, 2018.
- Debrus M. Pharmaciens et usagers, le dialogue nécessaire. http://www.asud.org/2007/06/07/pharmaciens-et-usagers-le-dialogue-necessaire/. Published June 7, 2007. Accessed December 21, 2018.
- Hoppe D, Ristevski E, Khalil H. The attitudes and practice strategies of community pharmacists towards drug misuse management: a scoping review. J Clin Pharm Ther. 2020;45(3):430–452.
- Stanbrook MB. Addiction is a disease: we must change our attitudes toward addicts. CMAJ. 2012;184(2):155.
- Stein MD, Anderson BJ, Bailey GL. Broken lives: fights, fractures, and motor vehicle accidents among heroin users entering detoxification. Drug Alcohol Depend. 2017;177:194–198.
- Wintemute GJ. Alcohol misuse, firearm violence perpetration, and public policy in the United States. Prev Med. 2015;79:15–21.
- Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Physicians’ beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists. Am J Addict. 2013;22(3):255–260.
- Dupouy J, Vergnes A, Laporte C, et al. Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice. Eur J Gen Pract. 2018;24(1):160–166.
- Lev-Ran S, Adler L, Nitzan U, Fennig S. Attitudes towards nicotine, alcohol and drug dependence among physicians in Israel. J Subst Abuse Treat. 2013;44(1):84–89.
- Ayu AP, van der Ven M, Suryani E, et al. Improving medical students’ attitude toward patients with substance use problems through addiction medicine education. Subst Abuse. 2020:1–9. DOI:https://doi.org/10.1080/08897077.2020.1732512
- Countey H, Steinbronn C, Grady SE. Changing student attitudes and perceptions toward opioid use disorder. Ment Health Clin. 2018;8(5):222–226.
- Sheridan J, Bates IP, Webb DG, Barber ND. Educational intervention in pharmacy students’ attitudes to HIV/AIDS and drug misuse. Med Educ. 1994;28(6):492–500.
- Crandall SJ, Davis SW, Broeseker AE, Hildebrandt C. A longitudinal comparison of pharmacy and medical students’ attitudes toward the medically underserved. Am J Pharm Educ. 2008;72(6):148.
- Journal Officiel de la République Française. LOI n° 2009-879 du 21 juillet 2009 portant réforme de l’hôpital et relative aux patients, à la santé et aux territoires. https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000020879475&categorieLien=id. Published 2009. Accessed November 2, 2017.
- von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
- Journal Officiel de la République Française. Arrêté Du 10 Janvier 2017 Fixant Le Nombre d’étudiants de Première Année Commune Aux Études de Santé Autorisés à Poursuivre Leurs Études En Pharmacie à La Suite Des Épreuves Terminales de l’année Universitaire 2016-2017 et Le Nombre d’étudiants Pouvant Être Admis Directement En Deuxième Année de Ces Études à La Rentrée Universitaire 2017-2018 En Application de l’article 9 Du Décret N° 2014-189 Du 20 Février 2014 Tendant à l’expérimentation de Modalités Particulières d’admission Dans Les Études Médicales, Odontologiques, Pharmaceutiques et Maïeutiques | Legifrance. https://www.legifrance.gouv.fr/eli/arrete/2017/1/10/AFSH1700601A/jo/texte/fr. Published 2017. Accessed July 10, 2017.
- Hasson D, Arnetz BB. Validation and findings comparing VAS vs. Likert scales for psychosocial measurements. Int Electron J Health Educ. 2005;8:178–192.
- Balayssac D, Pereira B, Darfeuille M, et al. Use of psychotropic medications and illegal drugs, and related consequences among French pharmacy students - SCEP study: a nationwide cross-sectional study. Front Pharmacol. 2018;9:725.
- Santé Publique France, Institut national du cancer. Avis d’experts relatif à l’évolution du discours public en matière de consommation d’alcool en France. https://www.santepubliquefrance.fr/content/download/2143/18554/version/3/file/avis_alcool_040517.pdf. Published May 4, 2017. Accessed May 7, 2019.
- Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
- Stockwell T, Zhao J, Greenfield T, Li J, Livingston M, Meng Y. Estimating under- and over-reporting of drinking in national surveys of alcohol consumption: identification of consistent biases across four English-speaking countries. Addict Abingdon Engl. 2016;111(7):1203–1213.
- Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8.
- Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Camb Mass. 1990;1(1):43–46.
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Mahwah, NJ: L. Erlbaum Associates; 1988.
- Nuzzo R. Scientific method: statistical errors. Nature. 2014;506(7487):150–152.
- Number crunch. Nature. 2014;506(7487):131–132.
- Altman DG. Practical Statistics for Medical Research. Covent Garden, UK: Chapman & Hall/CRC; 1999.
- Quince T, Thiemann P, Benson J, Hyde S. Undergraduate medical students’ empathy: current perspectives. Adv Med Educ Pract. 2016;7:443–455.
- Ordre National des Pharmaciens. Rôle des conseils de l’Ordre des pharmaciens dans les stages officinaux. http://www.ordre.pharmacien.fr/Nos-missions/Le-role-de-l-Ordre-dans-les-missions-de-sante-publique/Les-maitres-de-stage. Published February 21, 2017. Accessed July 22, 2020.
- Volkow ND. Stigma and the toll of addiction. N Engl J Med. 2020;382(14):1289–1290.
- Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review: Reducing substance use-related stigma. Addiction. 2012;107(1):39–50.
- Jarvi A, Hughes P, Shepherd JG, Hedgepeth Kennedy ML, Wilson CG. Impact of elective on students’ perceptions of treating patients with a substance use disorder. J Am Pharm Assoc. 2020;60(4):e43–e46.
- Muzyk A, Mullan P, Andolsek KM, et al. An interprofessional substance use disorder course to improve students’ educational outcomes and patients’ treatment decisions. Acad Med. 2019;94(11):1792–1799.
- Tobin H, Klimas J, Barry T, Egan M, Bury G. Opiate use disorders and overdose: medical students’ experiences, satisfaction with learning, and attitudes toward community naloxone provision. Addict Behav. 2018;86:61–65.
- Feeley RJ, Moore DT, Wilkins K, Fuehrlein B. A focused addiction curriculum and its impact on student knowledge, attitudes, and confidence in the treatment of patients with substance use. Acad Psychiatry. 2018;42(2):304–308.
- McGinty EE, Barry CL. Stigma reduction to combat the addiction crisis - developing an evidence base. N Engl J Med. 2020;382(14):1291–1292.
- Dumenco L, Monteiro K, Collins S, et al. A qualitative analysis of interprofessional students’ perceptions toward patients with opioid use disorder after a patient panel experience. Subst Abus. 2019;40(2):125–131.
- Palombi LC, Fike A, Chang C, Stratton TP, Koh-Knox C. How does a drug court experience influence student pharmacists? Curr Pharm Teach Learn. 2018;10(10):1331–1341.
- Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–207.
- McGinty EE, Goldman HH, Pescosolido B, Barry CL. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci Med. 2015;126:73–85.
- Kennedy-Hendricks A, McGinty EE, Barry CL. Effects of competing narratives on public perceptions of opioid pain reliever addiction during pregnancy. J Health Polit Policy Law. 2016;41(5):873–916.